Essex Investment Management’s Apyx Medical APYX Stock Holding History

Essex Investment Management’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.33M	Buy	+901,398	New	+$3.37M	0.53%	71
2023 Q4	–	Sell	-372,106	Closed	-$1.19M	–	321
2023 Q3	$1.19M	Buy	+372,106	New	+$1.73M	0.19%	162
2019 Q2	–	Sell	-256,755	Closed	-$1.62M	–	476
2019 Q1	$1.62M	Sell	256,755 -8,595	-3%	-$66.5K	0.24%	137
2018 Q4	$1.72M	Sell	265,350 -17,647	-6%	-$107K	0.27%	120
2018 Q3	$2.01M	Buy	282,997 +11,630	+4%	+$64.6K	0.24%	134
2018 Q2	$1.18M	Buy	+271,367	New	+$1M	0.15%	204

Other funds holding APYX

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Essex Investment Management's APYX Position: Q1 2026 in Review

Essex Investment Management opened a new position in Apyx Medical (APYX) in Q1 2026: 901,398 shares worth $3.33M. The stake represents 0.53% of the portfolio and ranks #71 among its holdings. This is a return to the name: Essex Investment Management previously reported a position in APYX as recently as Q3 2023.

Essex Investment Management first reported a position in APYX in Q2 2018 and has held it in 6 quarters since. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

Essex Investment Management held 901,398 shares of Apyx Medical worth $3.33M as of Q1 2026.
Apyx Medical was a new Essex Investment Management position in Q1 2026.
Apyx Medical made up 0.53% of Essex Investment Management's portfolio in Q1 2026, its #71 holding.
Essex Investment Management first reported a position in Apyx Medical in Q2 2018 and has held it in 6 quarters since.
67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Essex Investment Management's 13F filing for Q1 2026, filed 11 May 2026.